Home
McDermott Will & Emery
Glenn Engelmann
Glenn Engelmann
McDermott Will & Emery
FDA Issues Revised Draft Guidance On Disclosures Of Risk Information In Consumer-Friendly Print Advertisements And Promotional Labeling
23 Mar 2015 | United States
CMS Finalizes Proposal To Remove Continuing Medical Education Exclusion From Sunshine Act Regulations
13 Nov 2014 | United States
CMS Proposes Removing CME Exclusion From Sunshine Act Regulations, Citing Redundancy With Indirect Payment Exclusion
08 Aug 2014 | United States
Identifying And Mitigating Liabilities In Medical Device M&A
03 Jun 2014 | United States
FDA Updates Guidance Addressing Distribution Of Scientific And Medical Publications On Unapproved New Uses
10 Mar 2014 | United States
China Compliance Update: Commercial Bribery Risks Remain Very Real In China
15 Feb 2014 | China
FDA Issues Draft Guidance Addressing Postmarket Submission Requirements For Internet-based Promotional Materials
29 Jan 2014 | United States
New Law Extends Federal Oversight Of Compounding Pharmacies, Establishes National Drug Track-and-Trace Requirements
25 Jan 2014 | United States
Whistleblowing In China And The United States
24 Sep 2013 | China
Draft Guidance Outlines Recommendations For Formal Meetings Between FDA And Biosimilar Sponsors And Applicants
09 May 2013 | United States
Supreme Court Hears Oral Argument In "Pay-For-Delay" Patent Settlement Antitrust Case
08 Apr 2013 | United States
Federal Court Vacates Conviction For Truthful Off-Label Promotion Of FDA-Approved Drug
18 Dec 2012 | United States
New Flexibility For Pharmaceutical And Medical Device Companies In Massachusetts, But At A Price
09 Aug 2012 | United States
CMS To Extend Timetable For Implementation Of The Physician Payments Sunshine Act
14 May 2012 | United States
FDA Finalizes Benefit-Risk Determination Methodology For Certain Medical Devices
19 Apr 2012 | United States
FDA Schedules Public Hearing To Evaluate Potential New Drug Approval Paradigm
16 Apr 2012 | United States
FDA Issues Draft Guidance Implementing Direct-To-Consumer Television Ad Pre-Dissemination Review Program
13 Apr 2012 | United States
FDA Publishes Draft Biosimilars Guidance
22 Feb 2012 | United States
FDA Clarifies Use Of Product Names In Advertising And Promotional Labeling
07 Feb 2012 | United States
FDA Issues Draft Guidance, Requests Public Comments On Communication Of Off-Label Information
10 Jan 2012 | United States
Contact Details
Washington, DC
Washington, DC
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.